75 related articles for article (PubMed ID: 35503810)
1. Hepatocellular carcinoma in the world and the middle East.
Poustchi H; Sepanlou S; Esmaili S; Mehrabi N; Ansarymoghadam A
Middle East J Dig Dis; 2010 Jan; 2(1):31-41. PubMed ID: 25197510
[TBL] [Abstract][Full Text] [Related]
2. Problem of hepatocellular carcinoma in West Africa.
Ladep NG; Lesi OA; Mark P; Lemoine M; Onyekwere C; Afihene M; Crossey MM; Taylor-Robinson SD
World J Hepatol; 2014 Nov; 6(11):783-92. PubMed ID: 25429316
[TBL] [Abstract][Full Text] [Related]
3. Exploring Hepatocellular Carcinoma Risks in Sub-Saharan African and Afro-Surinamese Individuals with Chronic Hepatitis B living in Europe.
Tan MY; Su JH
J Hepatol; 2024 Apr; ():. PubMed ID: 38679067
[No Abstract] [Full Text] [Related]
4. Reply 'Exploring hepatocellular carcinoma risks in sub-Saharan African and Afro-Surinamese individuals with chronic hepatitis B living in Europe'.
Patmore LA; Sonneveld MJ
J Hepatol; 2024 Jun; ():. PubMed ID: 38871126
[No Abstract] [Full Text] [Related]
5. Hepatitis B.
Jeng WJ; Papatheodoridis GV; Lok ASF
Lancet; 2023 Mar; 401(10381):1039-1052. PubMed ID: 36774930
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B Virus X Protein Modulates p90 Ribosomal S6 Kinase 2 by ERK to Promote Growth of Hepatoma Cells.
Han N; Zhang Q; Tang X; Bai L; Yan L; Tang H
Viruses; 2023 May; 15(5):. PubMed ID: 37243268
[TBL] [Abstract][Full Text] [Related]
7. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review.
Alberts CJ; Clifford GM; Georges D; Negro F; Lesi OA; Hutin YJ; de Martel C
Lancet Gastroenterol Hepatol; 2022 Aug; 7(8):724-735. PubMed ID: 35576953
[TBL] [Abstract][Full Text] [Related]
8. The burden of cirrhosis and other chronic liver diseases due to hepatitis B in children and adolescents: results from global burden of disease study 2019.
Huang C; Wu Y; Zhang C; Ji D; Wang FS
Front Public Health; 2023; 11():1315392. PubMed ID: 38186703
[TBL] [Abstract][Full Text] [Related]
9. Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022).
You H; Wang F; Li T; Xu X; Sun Y; Nan Y; Wang G; Hou J; Duan Z; Wei L; Jia J; Zhuang H;
J Clin Transl Hepatol; 2023 Nov; 11(6):1425-1442. PubMed ID: 37719965
[TBL] [Abstract][Full Text] [Related]
10. The impact of immigration on hepatitis B burden in the United States: a modelling study.
Razavi-Shearer D; Gamkrelidze I; Pan CQ; Razavi-Shearer K; Blach S; Estes C; Mooneyhan E; Razavi H
Lancet Reg Health Am; 2023 Jun; 22():100516. PubMed ID: 37274551
[TBL] [Abstract][Full Text] [Related]
11. Racial Disparities in Treatment Initiation and Outcomes of Chronic Hepatitis B Virus Infection in North America.
Khalili M; Leonard KR; Ghany MG; Hassan M; Roberts LR; Sterling RK; Belle SH; Lok AS;
JAMA Netw Open; 2023 Apr; 6(4):e237018. PubMed ID: 37036707
[TBL] [Abstract][Full Text] [Related]
12. The Age, Gamma-Glutamyl Transpeptidase and Platelet Index: A Novel Noninvasive Model for Predicting Hepatocellular Carcinoma in Patients with Hepatitis B Virus-Related Liver Cirrhosis.
Liu K; Huang Z; Yang S; Lin L; Zheng S; Zhang X; Xue Y; Xie W
J Hepatocell Carcinoma; 2022; 9():1057-1063. PubMed ID: 36250136
[TBL] [Abstract][Full Text] [Related]
13. Comment on the risk of hepatocellular carcinoma with chronic hepatitis B infection in Sweden.
Singh SP; Mondia N
Hepatol Commun; 2022 Dec; 6(12):3592. PubMed ID: 35811444
[No Abstract] [Full Text] [Related]
14. Chronic hepatitis B virus infection and the risk of hepatocellular carcinoma by age and country of origin in people living in Sweden: A national register study.
Duberg AS; Lybeck C; Fält A; Montgomery S; Aleman S
Hepatol Commun; 2022 Sep; 6(9):2418-2430. PubMed ID: 35503810
[TBL] [Abstract][Full Text] [Related]
15. Age-specific and sex-specific risks for HCC in African-born persons with chronic hepatitis B without cirrhosis.
Kamal H; Ingre M; Stål P; Westman G; Bruce D; Wedemeyer H; Duberg AS; Aleman S
Hepatol Commun; 2023 Dec; 7(12):. PubMed ID: 38051538
[TBL] [Abstract][Full Text] [Related]
16. The impact of increased immigration to Sweden on the incidence and treatment of patients with HCC and underlying liver disease.
Taflin H; Hafström L; Holmberg E; Castedal M; Lindnér P
Scand J Gastroenterol; 2019 Jun; 54(6):746-752. PubMed ID: 31190577
[No Abstract] [Full Text] [Related]
17. Rates of cirrhosis and hepatocellular carcinoma in chronic hepatitis B and the role of surveillance: a 10-year follow-up of 673 patients.
Poh Z; Goh BB; Chang PE; Tan CK
Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):638-43. PubMed ID: 25831135
[TBL] [Abstract][Full Text] [Related]
18. Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis.
Raffetti E; Fattovich G; Donato F
Liver Int; 2016 Sep; 36(9):1239-51. PubMed ID: 27062182
[TBL] [Abstract][Full Text] [Related]
19. Chronic hepatitis B virus infection in Asian countries.
Merican I; Guan R; Amarapuka D; Alexander MJ; Chutaputti A; Chien RN; Hasnian SS; Leung N; Lesmana L; Phiet PH; Sjalfoellah Noer HM; Sollano J; Sun HS; Xu DZ
J Gastroenterol Hepatol; 2000 Dec; 15(12):1356-61. PubMed ID: 11197043
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
